Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation

Arthritis and Rheumatism

Volumn 63, Issue 2, 2011, Pages 373-381

  Stanczyk, Joanna ^a   Ospelt, Caroline ^a   Karouzakis, Emmanuel ^a   Filer, Andrew ^b   Raza, Karim ^b   Kolling, Christoph ^c   Gay, Renate ^a   Buckley, Christopher D ^b   Tak, Paul P ^d   Gay, Steffen ^a   Kyburz, Diego ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c SCHULTHESS CLINIC   (Switzerland)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; I KAPPA B KINASE; I KAPPA B KINASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; MICRORNA; MICRORNA 146A; MICRORNA 155; MICRORNA 203; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA METHYLATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; EPIGENESIS, GENETIC; FIBROBLASTS; GENE EXPRESSION; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 1; MICRORNAS; OSTEOARTHRITIS; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79551655444     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30115     Document Type: Article

References (41)

1. Ambros V,. The functions of animal microRNAs. Nature 2004; 431: 350-5.
2. Filipowicz W, Bhattacharyya SN, Sonenberg N,. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008; 9: 102-14.
3. Liu J,. Control of protein synthesis and mRNA degradation by microRNAs. Curr Opin Cell Biol 2008; 20: 214-21.
4. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP,. The impact of microRNAs on protein output. Nature 2008; 455: 64-71.
5. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD,. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 2008; 9: 839-45.
6. Mudhasani R, Zhu Z, Hutvagner G, Eischen CM, Lyle S, Hall LL, et al. Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells. J Cell Biol 2008; 181: 1055-63.
7. Tili E, Michaille JJ, Costinean S, Croce CM,. MicroRNAs, the immune system and rheumatic disease. Nat Clin Pract Rheumatol 2008; 4: 534-41.
8. Visone R, Croce CM,. MiRNAs and cancer. Am J Pathol 2009; 174: 1131-8.
9. Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK,. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008; 10: R101.
10. Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, et al. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 2008; 58: 1001-9.
11. Nakamachi Y, Kawano S, Takenokuchi M, Nishimura K, Sakai Y, Chin T, et al. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 2009; 60: 1294-304.
12. Nakasa T, Miyaki S, Okubo A, Hashimoto M, Nishida K, Ochi M, et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2008; 58: 1284-92.
13. Bueno MJ, Perez de Castro I, Gomez de Cedron M, Santos J, Calin GA, Cigudosa JC, et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 2008; 13: 496-506.
14. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J,. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31: 766-76.
15. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007; 67: 8699-707.
16. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J,. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008; 68: 2094-105.
17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
18. Li LC, Dahiya R,. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18: 1427-31.
19. Lewis BP, Burge CB, Bartel DP,. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
20. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37: 495-500.
21. Karouzakis E, Gay RE, Michel BA, Gay S, Neidhart M,. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2009; 60: 3613-22.
22. Miyazawa K, Mori A, Yamamoto K, Okudaira H,. Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: spontaneous activation of NF-κB and CBF1. Am J Pathol 1998; 152: 793-803.
23. Miyazawa K, Mori A, Okudaira H,. IL-6 synthesis by rheumatoid synoviocytes is autonomously upregulated at the transcriptional level. J Allergy Clin Immunol 1999; 103: S437-44.
24. Bondeson J, Brennan F, Foxwell B, Feldmann M,. Effective adenoviral transfer of IκBα into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines is nuclear factor-κB dependent. J Rheumatol 2000; 27: 2078-89.
25. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007; 25: 387-92.
26. Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P, Taubert H,. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer; 126: 73-80.
27. Petillo D, Kort EJ, Anema J, Furge KA, Yang XJ, Teh BT,. MicroRNA profiling of human kidney cancer subtypes. Int J Oncol 2009; 35: 109-14.
28. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008; 299: 425-36.
29. Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, et al. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 2008; 135: 255-60.
30. Sonkoly E, Wei T, Janson PC, Saaf A, Lundeberg L, Tengvall-Linder M, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One 2007; 2: e610.
31. Yi R, Poy MN, Stoffel M, Fuchs E,. A skin microRNA promotes differentiation by repressing 'stemness.' Nature 2008; 452: 225-9.
32. Goodman WA, Levine AD, Massari JV, Sugiyama H, McCormick TS, Cooper KD,. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol 2009; 183: 3170-6.
33. Ospelt C, Gay S,. The role of resident synovial cells in destructive arthritis. Best Pract Res Clin Rheumatol 2008; 22: 239-52.
34. Maini RN, Taylor PC, Szechinski J, Pavelka K, Broll J, Balint G, et al, for the CHARISMA Study Group. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum 2006; 54: 2817-29.
35. Tak PP, Smeets TJ, Daha MR, Kluin PM, Meijers KA, Brand R, et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 1997; 40: 217-25.
36. Weber B, Stresemann C, Brueckner B, Lyko F,. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 2007; 6: 1001-5.
37. Sheedy FJ, O'Neill LA,. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis 2008; 67 Suppl III: iii50-5.
38. Trang P, Weidhaas JB, Slack FJ,. MicroRNAs as potential cancer therapeutics. Oncogene 2008; 27 Suppl 2: S52-7.
39. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456: 980-4.
40. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137: 1005-17.
41. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327: 198-201.